Promising stratagems for reducing the burden of neonatal sepsis

Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F150-3. doi: 10.1136/fn.83.2.f150.

Authors

N Modi¹, R Carr

Affiliation

¹ Division of Paediatrics and Neonatal Medicine, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. [email protected]

No abstract available

Publication types

Review

MeSH terms

Bacterial Infections / drug therapy*
Bacterial Infections / etiology
Bacterial Infections / prevention & control
Controlled Clinical Trials as Topic
Granulocyte Colony-Stimulating Factor / pharmacology
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Immunoglobulins, Intravenous / therapeutic use
Infant, Newborn
Infant, Premature*
Infant, Small for Gestational Age*
Neutropenia / complications
Neutrophils / drug effects
Recombinant Proteins
Research Design
Treatment Outcome

Substances

Immunoglobulins, Intravenous
Recombinant Proteins
Granulocyte Colony-Stimulating Factor